Frenova Renal Research has added an additional location to its roster of managed clinical research sites. The new capacity will enhance Frenova’s ability to help clinical research sponsors enroll patients rapidly and streamline clinical trials.
"We look forward to managing this site and working alongside our new partner investigators. Increasing our network of investigators and pool of patients allows our clients to significantly accelerate their clinical trials designed to ultimately better the lives of those living with renal disease,” said Kurt Mussina, vice president, FMCNA, and general manager, Frenova Renal Research. “Between 2016 and 2018, we reduced the time from clinical trial agreement to first-patient-first-visit by over 80 percent among the sites we manage.”
“The new manager Frenova brought in is already streamlining our research activities,” said Dr. Samuel Kantor, one of the principal investigators (PI) at Nevada Kidney Disease and Hypertension Centers. “We can already see that Frenova is going to make our work a lot more efficient,” said its other PI, Dr. Jeffrey Ryu.